SCHEMBL29500415

SCHEMBL29500415

O=C(NCCc1ccc(O)cc1)/C(Cc1ccc(O)cc1)=N/O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 9/20 0.78
▸ CA2 P00918 9/20 0.78
▸ CA9 Q16790 6/20 0.78
▸ CA12 O43570 6/20 0.78
▸ HDAC1 Q13547 5/20 0.73
▸ HDAC6 Q9UBN7 5/20 0.73
▸ HDAC3 O15379 4/20 0.73
▸ HDAC4 P56524 4/20 0.73
▸ HDAC7 Q8WUI4 4/20 0.73
▸ HDAC2 Q92769 4/20 0.73
▸ HDAC10 Q969S8 4/20 0.73
▸ HDAC11 Q96DB2 4/20 0.73
▸ HDAC8 Q9BY41 4/20 0.73
▸ HDAC9 Q9UKV0 4/20 0.73
▸ HDAC5 Q9UQL6 4/20 0.73
▸ CTBP2 P56545 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.56
▸ F13A1 P00488 1/20 0.56
▸ PLK4 O00444 1/20 0.54
▸ AURKA O14965 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4161209 0.78 ESRRB (0.77) CA1CA2CA9CA12KDM4E
Hemibastadin 1 SCHEMBL4751505 0.77 PLK4 (0.82) CA1CA2CA9CA12HDAC1
SCHEMBL15358690 0.76 KDM4E (0.73) CA1CA2CA9CA12KDM4E
SCHEMBL11282868 0.75 CTBP2 (1.00) CA1CA2CA9CA12HDAC1
SCHEMBL11282864 0.75 CTBP2 (1.00) CA1CA2CA9CA12HDAC1
SCHEMBL105520 0.75 KDM4E (0.71) CA1CA2CA9CA12KDM4E
SCHEMBL30378788 0.74 CTBP2 (0.70) CA1CA2CA9CA12HDAC1
SCHEMBL30988765 0.74 PLK4 (0.71) CA1CA2CA9CA12HDAC1
Hemibastadin 2 SCHEMBL6803113 0.74 PLK4 (0.89) CA1CA2CA9CA12HDAC1
SCHEMBL6797800 0.74 PLK4 (0.80) CA1CA2CA9CA12HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085768-A1 FUSION POLYPEPTIDES AND APPLICATIONS THEREOF GELTOR, INC. (US) 2025-04-24 — — WO disclosed
CN-119143966-A Preparation method of polyurethane polymer, hemostatic cotton and drug sustained-release system 浦易(上海)生物技术股份有限公司 2024-12-17 — — CN disclosed
CN-118043298-A (Hetero) aryl-substituted bisphenol compound and thermoplastic resin 罗伊特化学仪器制造公司 2024-05-14 — — CN disclosed
CN-117940399-A Heteroaryl or aryl substituted bisphenol compounds and thermoplastic resins 三菱瓦斯化学株式会社 2024-04-26 — — CN disclosed
US-20230418051-A1 MONOLITHIC MIRROR AND METHOD FOR DESIGNING SAME SILBAT ENERGY SOLUTIONS, S.L. (ES) 2023-12-28 — — US disclosed
US-11753524-B2 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions PLASTIPAK PACKAGING, INC. (US) 2023-09-12 — — US disclosed
US-20220073700-A1 OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT 2022-03-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073700-A1 OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS PRDX5, LPO, CAT CA1 453/4885CA2 274/4885CA9 670/4885
US-11753524-B2 Oxygen scavengers, compositions comprising the scavengers, and articles made from the compositions PRDX5, LPO, CAT CA1 453/4885CA2 274/4885CA9 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback